Unknown PHASE2/PHASE3 INTERVENTIONAL 2-arm
NCT01301937
Low Antimonial Dosage in American Mucosal Leishmaniasis
Phase III Clinical Trial for Mucosal or Mucocutaneous Leishmaniasis. Comparison Between the Standard and Alternative Antimonial Schemes
Sponsor: Conselho Nacional de Desenvolvimento Científico e Tecnológico
Conditions
Mucocutaneous Leishmaniasis Mucosal Leishmaniasis
Interventions
Meglumine antimoniate
Last updated: Jul 10, 2018 Started: Oct 31, 2008 Primary completion: Dec 31, 2020 Completion: Dec 31, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE2/PHASE3 trial investigates Mucocutaneous Leishmaniasis and Mucosal Leishmaniasis and is currently ongoing. Conselho Nacional de Desenvolvimento Científico e Tecnológico leads this study, which shows 0 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Change History
No change history available.
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Oswaldo Cruz Foundation
- Rio de Janeiro State Research Supporting Foundation (FAPERJ)
Data source: Oswaldo Cruz Foundation
For direct contact, visit the study record on ClinicalTrials.gov .